Our Mission
Our mission is to develop and apply innovative technologies that advance therapeutic discovery against difficult protein targets.
With 20+ years of experience focusing on membrane proteins and antibodies, our technologies have enabled hundreds of companies worldwide working in research, drug discovery, and vaccine development.

Trusted Results
Integral Molecular's leadership team has been working together since 2001, creating innovative products and technologies to address complex scientific questions.

Who We Are
Integral Molecular is a founding member of Philadelphia’s biotech community, launched by a team of scientists who met as graduate students and postdocs at the University of Pennsylvania. Our core leadership team has worked together since 2001 to build the company from a two-person laboratory to the industry leader in membrane protein solutions.
"The scientists at Integral Molecular do not shy away from the most difficult drug targets. The scientific team is dynamic, hard-working, and able to drive great science to new levels.“
- Thomas Charpentier, Integral Molecular Alum (Protein Engineering)


Integral to the Community
With deep roots in Philadelphia, Integral Molecular strives to actively engage local students and community members with STEM educational initiatives. We are proud to work with our local community and hope to inspire a new generation of scientists.




Research Facilities
Our 50,000 sq. ft. research center is heavily invested in state-of-the-art cell and molecular biology, robotics, high-throughput instrumentation, and technology to enable us to solve difficult challenges and advance therapeutic discovery.
Integral Molecular’s research facility is located at the junction of innovation and entrepreneurship within the University City Science Center, the country’s largest urban research park. Surrounded by top-tier universities, medical centers, and biotech companies, Integral Molecular thrives with an energetic backdrop of technology and talent that includes the University of Pennsylvania, Spark Therapeutics, Amicus Therapeutics, the Children's Hospital of Philadelphia, and the Wistar Institute.

Trusted by Over 600 Companies
